Matthew B. Zamora, PA-C

Matthew Zamora practices at McLaren Medical Group in Itasca, Illinois.

Matthew Zamora's NPI, 1659883676, was assigned on October 31, 2017. Matthew Zamora holds Michigan license 5601008472.

Matthew Zamora's primary practice is McLaren Medical Group, at 350 E Devon Ave, Itasca, IL 60143 in Dupage County. The practice phone is (810) 664-4531.

Matthew Zamora's primary practice is McLaren Medical Group in Itasca, Illinois. Matthew Zamora is also affiliated with MyMichigan Medical Center Midland. The medical group on file is McLaren Lapeer Region Community Medical Center. Dmand AI also links Matthew Zamora to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Zamora practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Matthew Zamora's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Matthew Zamora is licensed in Michigan.

CMS data shows 426 Medicare services from Matthew Zamora across 5 procedure codes in 2024, for 202 Medicare patients. Medicare paid $25,900 for them. Every service was in an office.

CMS counts 202 Medicare patients who saw Matthew Zamora in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Zamora's median patient age at 64, with 52% women.

In 2024, Matthew Zamora wrote 5,977 Medicare Part D claims for 744 patients. 83% of them were for generic drugs. CMS names the drug for 5,198 of them, across 120 drugs with 11 or more claims each, at $585,500 in total drug cost. In 2023, CMS named 5,859 claims across 125 drugs.

Matthew Zamora accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Zamora as offering telehealth.

CMS Open Payments shows 307 general payments to Matthew Zamora from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 96% of the total. Eli Lilly and Company paid the most, $755.